STATEMENT: Tsingke presents cutting-edge biological solutions at Biologics 2024

(Information sent by the signatory company).

STATEMENT: Tsingke presents cutting-edge biological solutions at Biologics 2024

(Information sent by the signatory company)

BEIJING and PARIS, April 11, 2024 /PRNewswire/ -- On March 15, Biologics 2024 concluded successfully in London, with 650 pharmaceutical, biotech and academic representatives and more than 50 exhibitors participating in high-level discussions on the latest innovations in the discovery and development of biological products.

Tsingke, as a pioneer in DNA/RNA synthesis technology, was honored to share its cutting-edge innovative products, services and latest advances with attendees.

During in-depth discussions with numerous professionals and exhibitors, they were impressed by Tsingke's leadership positions in the fields of oligosynthesis and gene synthesis services, and most of them expressed great interest in collaborating.

Product Highlights

Oligonucleotide synthesis: Tsingke offers a wide range of oligonucleotide products, including custom DNA/RNA oligos, qPCR probes and NGS oligos. With ISO 13485 certification and a commitment to customer trust, Tsingke serves more than 500 in vitro diagnostic companies with high-quality nucleic acid synthesis.

Tsynth™ Gene Synthesis: Tsingke's flagship product, Tsynth™ Gene Synthesis, is at the forefront of gene synthesis technology. Researchers benefit from high precision and fast response time, ensuring stable and efficient gene synthesis.

Protein Expression: Providing a comprehensive service from gene synthesis to protein expression, Tsingke's five core systems offer researchers a variety of options for specific needs. Additionally, our high-throughput expression platform delivers high purity products with fast turnaround times, accelerating research projects around the world.

Antibody Service: Tsingke provides a comprehensive service platform from gene expression to antibodies to meet broad needs of specific applications. Focusing on traceability and high-expression titles, Tsingke ensures the highest standards of quality and compliance.

About Tsingke

Beijing Tsingke Biotech Co., Ltd. is the pioneering company in DNA/RNA synthesis, distinguished by its innovative R&D capabilities and commitment to continuous improvement in synthetic instruments, raw materials and automated production systems. With the mission of promoting "Biotechnology for a Better World", Tsingke is dedicated to innovation and quality, serving researchers and companies globally.

To learn more about Tsingke and its revolutionary bio-based solutions, visit https://www.tsingke.com/

Photo - https://mma.prnewswire.com/media/2382387...

View original content: https://www.prnewswire.com/news-releases/tsingke-presenta-soluciones-biologicas-de-vanguardia-en-biologics-2024-302113760.html

NEXT NEWS